Mikhail Valkov to Registries
This is a "connection" page, showing publications Mikhail Valkov has written about Registries.
Connection Strength
0.438
-
[Increment of the incidence of glioblastoma following decrease in the incidence of brain tumors in 2000-2020: a population-based registry study]. Zh Vopr Neirokhir Im N N Burdenko. 2022; 86(5):28-36.
Score: 0.126
-
Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study. Int Health. 2018 03 01; 10(2):92-99.
Score: 0.097
-
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 2023 03 14; 25(3):580-592.
Score: 0.034
-
World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3). Cancer Epidemiol. 2022 10; 80:102196.
Score: 0.033
-
Comparison of female breast cancer between Russia and Germany: A population-based study on time trends and stage at diagnosis. Cancer Epidemiol. 2022 10; 80:102214.
Score: 0.033
-
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022 06; 6(6):409-431.
Score: 0.032
-
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro Oncol. 2021 10 01; 23(10):1765-1776.
Score: 0.031
-
A cross-national perspective of migration and cancer: incidence of five major cancer types among resettlers from the former Soviet Union in Germany and ethnic Germans in Russia. BMC Cancer. 2019 Sep 02; 19(1):869.
Score: 0.027
-
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 03 17; 391(10125):1023-1075.
Score: 0.024